| Date Filed | Type | Description |
| 08/21/2023 |
4
| Shah Gaurav (CEO) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.|
Txns:
| Sold 4,767 shares
@ $15.471, valued at
$73.8k
|
|
| 08/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/15/2023 |
4
| Shah Gaurav (CEO) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.|
Txns:
| Exercised 7,979 restricted stock units
@ $0 |
|
| 05/19/2023 |
4
| Shah Gaurav (CEO) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.|
Txns:
| Sold 4,122 shares
@ $21.375, valued at
$88.1k
|
|
| 05/16/2023 |
4
| Shah Gaurav (CEO) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.|
Txns:
| Exercised 7,979 restricted stock units
@ $0 |
|
| 03/31/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 02/22/2023 |
4
| Shah Gaurav (CEO) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.|
Txns:
| Sold 12,194 shares
@ $19.06, valued at
$232.4k
|
|
| 02/22/2023 |
4/A
| Shah Gaurav (CEO) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.|
Txns:
| Granted 348,590 options to buy
@ $20.04, valued at
$7M
Granted 116,317 restricted stock units
@ $0
Exercised 31,440 options to buy
@ $0 |
|
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2022 |
4
| Shah Gaurav (CEO) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.|
Txns:
| Granted 297,037 options to buy
@ $20, valued at
$5.9M
Granted 95,275 restricted stock units
@ $0 |
|
| 02/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
5
| Shah Gaurav (President & CEO) has filed a Form 5 on ROCKET PHARMACEUTICALS, INC. |
| 02/08/2021 |
4
| Shah Gaurav (President & CEO) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.|
Txns:
| Granted 185,000 options to buy
@ $62.32, valued at
$11.5M
|
|
| 03/26/2020 |
4
| Shah Gaurav (President & CEO) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.|
Txns:
| Exercised 90,925 shares
@ $0.43, valued at
$39.1k
Paid exercise price by delivering 32,645 shares
@ $13.78, valued at
$449.8k
Exercised 90,925 options to buy
@ $0.44, valued at
$40k
|
|
| 02/27/2020 |
4
| Shah Gaurav (President & CEO) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.|
Txns:
| Exercised 290,000 shares
@ $0.4332, valued at
$125.6k
Paid exercise price by delivering 6,233 shares
@ $20.15, valued at
$125.6k
Exercised 290,000 options to buy
@ $0.44, valued at
$127.6k
|
|
| 02/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/05/2019 |
4
| Shah Gaurav (See Remarks) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.|
Txns:
| Sold 25,000 shares
@ $17.34, valued at
$433.5k
Sold 24,900 shares
@ $17.28, valued at
$430.3k
Sold 25,000 shares
@ $16.9, valued at
$422.5k
|
|
| 01/30/2019 |
4
| Shah Gaurav (See Remarks) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.|
Txns:
| Granted 315,700 options to buy
@ $14.56, valued at
$4.6M
|
|
| 04/02/2018 |
4
| Shah Gaurav (See Remarks) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.|
Txns:
| Granted 395,000 options to buy
@ $18.75, valued at
$7.4M
|
|
| 01/16/2018 |
3
| Shah Gaurav (See Remarks) has filed a Form 3 on ROCKET PHARMACEUTICALS, INC. |